Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma. | Oncol Res | 2023 | 37547764 | PubTator, text mining | PubMed |
| Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis. | Front Oncol | 2023 | 37534253 | PubTator, text mining | PubMed |
| Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans. | Sci Transl Med | 2023 | 37531413 | PubTator, text mining | PubMed |
| The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis. | Biomark Insights | 2023 | 37528936 | PubTator, text mining | PubMed |
| Engineering a CEACAM1 Variant with the Increased Binding Affinity to TIM-3 Receptor | Iran Biomed J | 2023 | 37525418 | PubTator, text mining | PubMed |
| System Biology Approach to Identify the Hub Genes and Pathways Associated with Human H5N1 Infection. | Vaccines (Basel) | 2023 | 37515084 | PubTator, text mining | PubMed |
| Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37511031 | PubTator, text mining | PubMed |
| TIME Is Ticking for Cervical Cancer. | Biology (Basel) | 2023 | 37508372 | PubTator, text mining | PubMed |
| The double-edged role of neutrophil heterogeneity in inflammatory diseases and cancers. | MedComm (2020) | 2023 | 37492784 | PubTator, text mining | PubMed |
| M1-Type Macrophages Secrete TNF-α to Stimulate Vascular Calcification by Upregulating CA1 and CA2 Expression in VSMCs. | J Inflamm Res | 2023 | 37489150 | PubTator, text mining | PubMed |
| T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans. | Gastroenterology | 2023 | 37479191 | PubTator, text mining | PubMed |
| Retracted: Serum Level of CEACAM1 in Patients with Nonsmall Cell Lung Cancer and Its Clinical Significance in Cancer Tissue. | J Healthc Eng | 2023 | 37476816 | PubTator, text mining | PubMed |
| Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion. | Cancer Cell Int | 2023 | 37468844 | PubTator, text mining | PubMed |
| An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer. | Adv Ther | 2023 | 37462865 | PubTator, text mining | PubMed |
| Integrated multiomic analysis and high-throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy. | MedComm (2020) | 2023 | 37457661 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Biocompatibility Assessment of a Thermosensitive Injectable Chitosan-Based Hydrogel for Musculoskeletal Tissue Engineering. | Int J Mol Sci | 2023 | 37445622 | PubTator, text mining | PubMed |
| Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2023 | 37444609 | PubTator, text mining | PubMed |
| Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. | Front Oncol | 2023 | 37427115 | PubTator, text mining | PubMed |
| Distinct functional constraints driving conservation of the cofilin N-terminal regulatory tail. | bioRxiv | 2023 | 37425676 | PubTator, text mining | PubMed |
| SpatialDM for rapid identification of spatially co-expressed ligand-receptor and revealing cell-cell communication patterns. | Nat Commun | 2023 | 37414760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=17